Pfizer Inc Stock Price Prediction

PFE Stock  USD 27.78  0.19  0.69%   
At the present time, The relative strength index (RSI) of Pfizer's share price is at 58 indicating that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling Pfizer, making its price go up or down.

Oversold Vs Overbought

58

 
Oversold
 
Overbought
Pfizer Inc stock price prediction is an act of determining the future value of Pfizer shares using few different conventional methods such as EPS estimation, analyst consensus, or fundamental intrinsic valuation. The successful prediction of Pfizer's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Pfizer and does not consider all of the tangible or intangible factors available from Pfizer's fundamental data. We analyze noise-free headlines and recent hype associated with Pfizer Inc, which may create opportunities for some arbitrage if properly timed.
Below are the key fundamental drivers impacting Pfizer's stock price prediction:
Quarterly Earnings Growth
(0.76)
EPS Estimate Next Quarter
0.53
EPS Estimate Current Year
2.2
EPS Estimate Next Year
2.76
Wall Street Target Price
32.18
It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. We use our internally-built news screening methodology to estimate the value of Pfizer based on different types of headlines from major news networks to social media. The Pfizer stock price prediction module provides an analysis of price elasticity to changes in media outlook on Pfizer over a specific investment horizon. Using Pfizer hype-based prediction, you can estimate the value of Pfizer Inc from the perspective of Pfizer response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Pfizer using Pfizer's stock options and short interest. It helps to benchmark the overall future attitude of investors towards Pfizer using crowd psychology based on the activity and movement of Pfizer's stock price.

Pfizer Short Interest

A significant increase or decrease in Pfizer's short interest from the previous month could be a good indicator of investor sentiment towards Pfizer. Short interest can provide insight into the potential direction of Pfizer stock and how bullish or bearish investors feel about the market overall. An investor who is long Pfizer may also wish to track short interest. As short interest increases, investors should be becoming more worried about Pfizer and may potentially protect profits, hedge Pfizer with its derivative instruments, or be ready for some potential downside.
200 Day MA
31.7272
Short Percent
0.0117
Short Ratio
1.53
Shares Short Prior Month
60.2 M
50 Day MA
27.4808

Pfizer Inc Hype to Price Pattern

Investor biases related to Pfizer's public news can be used to forecast risks associated with an investment in Pfizer. The trend in average sentiment can be used to explain how an investor holding Pfizer can time the market purely based on public headlines and social activities around Pfizer Inc. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Pfizer's market sentiment to its price can help taders to make decisions based on the overall investors consensus about Pfizer.

Pfizer Implied Volatility

    
  52.55  
Pfizer's implied volatility exposes the market's sentiment of Pfizer Inc stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Pfizer's implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Pfizer stock will not fluctuate a lot when Pfizer's options are near their expiration.
This module is based on analyzing investor sentiment around taking a position in Pfizer. This speculative approach is based exclusively on the idea that markets are driven by emotions such as investor fear and greed. The fear of missing out, i.e., FOMO, can cause potential investors in Pfizer to buy its stock at a price that has no basis in reality. In that case, they are not buying Pfizer because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell stocks at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Pfizer after-hype prediction price

    
  USD 27.79  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.

Prediction based on Rule 16 of the current Pfizer contract

Based on the Rule 16, the options market is currently suggesting that Pfizer Inc will have an average daily up or down price movement of about 3.28% per day over the life of the 2024-03-28 option contract. With Pfizer trading at USD 27.78, that is roughly USD 0.91 . If you think that the market is fully incorporating Pfizer's daily price movement you should consider acquiring Pfizer Inc options at the current volatility level of 52.55%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
  
Check out Pfizer Basic Forecasting Models to cross-verify your projections.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Pfizer's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
25.0033.1834.60
Details
Naive
Forecast
LowNextHigh
26.2627.6829.11
Details
25 Analysts
Consensus
LowTargetHigh
35.1938.6742.92
Details
Earnings
Estimates (0)
LowProjected EPSHigh
0.370.540.82
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Pfizer. Your research has to be compared to or analyzed against Pfizer's peers to derive any actionable benefits. When done correctly, Pfizer's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Pfizer Inc.

Pfizer After-Hype Price Prediction Density Analysis

As far as predicting the price of Pfizer at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Pfizer or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Pfizer, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Pfizer Estimiated After-Hype Price Volatility

In the context of predicting Pfizer's stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Pfizer's historical news coverage. Pfizer's after-hype downside and upside margins for the prediction period are 26.37 and 29.21, respectively. We have considered Pfizer's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models outperform traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
27.78
27.79
After-hype Price
29.21
Upside
Pfizer is very steady at this time. Analysis and calculation of next after-hype price of Pfizer Inc is based on 3 months time horizon.

Pfizer Stock Price Prediction Analysis

Have you ever been surprised when a price of a Company such as Pfizer is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Pfizer backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Pfizer, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
  0.02 
1.43
 0.00  
  0.03 
9 Events / Month
6 Events / Month
In about 9 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
27.78
27.79
0.04 
650.00  
Notes

Pfizer Hype Timeline

On the 28th of March Pfizer Inc is traded for 27.78. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.03. Pfizer is forecasted to increase in value after the next headline, with the price projected to jump to 27.79 or above. The average volatility of media hype impact on the company the price is over 100%. The price growth on the next news is projected to be 0.04%, whereas the daily expected return is at this time at -0.02%. The volatility of related hype on Pfizer is about 98.18%, with the expected price after the next announcement by competition of 27.81. The company reported the last year's revenue of 58.5 B. Total Income to common stockholders was 2.13 B with profit before taxes, overhead, and interest of 66.23 B. Considering the 90-day investment horizon the next forecasted press release will be in about 9 days.
Check out Pfizer Basic Forecasting Models to cross-verify your projections.

Pfizer Related Hype Analysis

Having access to credible news sources related to Pfizer's direct competition is more important than ever and may enhance your ability to predict Pfizer's future price movements. Getting to know how Pfizer rivals react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Pfizer may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
AAgilent Technologies 3.49 11 per month 1.43 (0.02) 2.27 (2.26) 5.92 
MBIOMustang Bio(0.04)3 per month 0.00 (0.12) 5.30 (8.49) 20.58 
MBRXMoleculin Biotech 5.79 9 per month 0.00 (0.11) 11.19 (11.18) 34.21 
CLVRWClever Leaves Holdings 0.01 2 per month 7.03  0.17  29.03 (12.50) 74.95 
MCRBSeres Therapeutics 0.01 10 per month 0.00 (0.09) 8.70 (8.33) 29.80 
MDGLMadrigal Pharmaceuticals 4.05 8 per month 4.45  0.04  8.89 (7.09) 24.70 
EQEquillium(0.15)10 per month 5.96  0.20  20.33 (10.80) 70.42 
KAKineta Inc(0.02)7 per month 0.00 (0.26) 8.68 (9.84) 72.56 
ME23Andme Holding Co(0.03)11 per month 0.00 (0.11) 10.61 (10.00) 34.64 

Pfizer Additional Predictive Modules

Most predictive techniques to examine Pfizer price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Pfizer using various technical indicators. When you analyze Pfizer charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Pfizer Predictive Indicators

The successful prediction of Pfizer stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Pfizer Inc, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Pfizer based on analysis of Pfizer hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Pfizer's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Pfizer's related companies.
 2021 2022 2023 2024 (projected)
Price Earnings Ratio15.059.1676.6780.5
Short Term Coverage Ratios14.549.940.80.76

Story Coverage note for Pfizer

The number of cover stories for Pfizer depends on current market conditions and Pfizer's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Pfizer is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Pfizer's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.

Pfizer Short Properties

Pfizer's future price predictability will typically decrease when Pfizer's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Pfizer Inc often depends not only on the future outlook of the potential Pfizer's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Pfizer's indicators that are reflective of the short sentiment are summarized in the table below.
Common Stock Shares Outstanding5.7 B
Cash And Short Term Investments12.7 B
When determining whether Pfizer Inc is a strong investment it is important to analyze Pfizer's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Pfizer's future performance. For an informed investment choice regarding Pfizer Stock, refer to the following important reports:
Check out Pfizer Basic Forecasting Models to cross-verify your projections.
Note that the Pfizer Inc information on this page should be used as a complementary analysis to other Pfizer's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.

Complementary Tools for Pfizer Stock analysis

When running Pfizer's price analysis, check to measure Pfizer's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pfizer is operating at the current time. Most of Pfizer's value examination focuses on studying past and present price action to predict the probability of Pfizer's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pfizer's price. Additionally, you may evaluate how the addition of Pfizer to your portfolios can decrease your overall portfolio volatility.
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
Is Pfizer's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Pfizer. If investors know Pfizer will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Pfizer listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
(0.76)
Dividend Share
1.64
Earnings Share
0.37
Revenue Per Share
10.366
Quarterly Revenue Growth
(0.41)
The market value of Pfizer Inc is measured differently than its book value, which is the value of Pfizer that is recorded on the company's balance sheet. Investors also form their own opinion of Pfizer's value that differs from its market value or its book value, called intrinsic value, which is Pfizer's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Pfizer's market value can be influenced by many factors that don't directly affect Pfizer's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Pfizer's value and its price as these two are different measures arrived at by different means. Investors typically determine if Pfizer is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Pfizer's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.